Epithalon

Overview

Epithalon is a synthetic analog of Epithalamin, a naturally occurring polypeptide derived from the pineal gland. Its amino acid sequence — Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly) — is the smallest structural unit identified as biologically active within Epithalamin research. Preclinical investigation into Epithalon has focused on its effects on telomerase, the enzyme responsible for maintaining and restoring telomere sequences at chromosome ends. Telomere shortening is an established marker of cellular aging, and telomerase activity has been examined in cellular aging and genomic stability research.

Beyond telomere biology, Epithalon has been studied in preclinical models for gene expression modulation, skin and connective tissue dynamics, oncology research, and retinal function. The research profile spans in vitro work on human somatic cell lines and in vivo preclinical models.

Chemical Profile

Preclinical Research Findings

Telomerase Activity and Cellular Aging Research

Epithalon has been studied for its effects on telomerase activity in both in vitro and in vivo preclinical models. In vitro research using human somatic cell lines reported telomerase induction and telomere elongation following Epithalon treatment, representing an experimental model of chromosomal maintenance. Preclinical studies in insects and rodents have examined the relationship between Epithalon administration and age-associated biological parameters, including observations on cellular aging markers and survival-related endpoints. Antioxidant activity has been proposed as an additional mechanism, and Epithalon has been examined in the context of telomere biology and cellular senescence research.

Gene Expression and Cellular Signaling Research

Research into the molecular mechanisms of Epithalon has demonstrated interactions with gene promoter regions in preclinical models. Studies examining short cell-penetrating peptides, including Epithalon, have reported modulation of genes involved in immune signaling (CD5, IL-2), connective tissue remodeling (MMP2, Tram1), and melatonin biosynthesis (AANAT, pCREB). These promoter-level interactions suggest a mechanism by which Epithalon may influence transcriptional activity across multiple cellular systems. This line of research has been pursued primarily in vitro and in preclinical genomic models.

Skin and Connective Tissue Research

Preclinical models examining Epithalon’s effects on skin biology have focused on fibroblast function and extracellular matrix regulation. Research has reported Epithalon-associated stimulation of fibroblast activity and modulation of MMP2 expression, an enzyme involved in extracellular matrix turnover. These findings have been studied in the context of connective tissue maintenance and dermal aging research. In vivo preclinical models have examined changes in skin structure and wound-associated parameters following Epithalon administration.

Oncology and Tumor Biology Research

Epithalon has been studied in preclinical oncology models for its potential effects on tumor development. Research in rodent models examining spontaneous carcinogenesis reported observations related to tumor incidence and progression following Epithalon administration. These findings have been investigated in the context of age-related tumor biology and the relationship between cellular aging mechanisms and cancer development. Results from preclinical models require further investigation before any conclusions can be drawn about translational relevance.

Visual and Retinal Function Research

Preclinical research has examined Epithalon in models of retinal degeneration. Studies using animal models of retinitis pigmentosa reported observations on retinal morphology and visual function parameters following Epithalon administration. This area of investigation is among the more disease-specific applications examined in Epithalon preclinical research, and findings are limited to experimental models at this stage.

Areas of Preclinical Research

• Telomerase activation and telomere dynamics in preclinical models
• Cellular aging and senescence research
• Gene promoter interaction and transcriptional signaling studies
• Skin fibroblast activity and extracellular matrix modeling
• Tumor biology and oncology modeling
• Retinal function and ophthalmological modeling

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.